Hot Features
Premium
Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
| Nom Action | Symbole Action | Marché | Type |
|---|---|---|---|
| Gyre Therapeutics Inc | GYRE | NASDAQ | Action ordinaire |
| Variation Action | Variation Action% | Cours Dernier | Dernier échange
|
|
|---|---|---|---|---|
| 0,28 | 1,79% | 15,91 | 16:39:21 |
| Ouverture | Plus Bas | Plus Haut | Prix de clôture | Clôture Veille |
|---|---|---|---|---|
| 15,45 | 15,45 | 15,91 | 15,63 |
Actualités Recentes
| Date | Heure | Source | Titre |
|---|---|---|---|
| 13/5/2024 | 22:07 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 09/5/2024 | 22:10 | GLOBE | Gyre Therapeutics Reports First Quarter 2024 Financial.. |
| 09/5/2024 | 22:05 | EDGAR2 | Form 8-K - Current report |
| 08/5/2024 | 14:00 | EDGAR2 | Form 8-K - Current report |
| 26/3/2024 | 11:00 | GLOBE | Gyre Therapeutics Reports Full Year 2023 Financial Results.. |
| 21/3/2024 | 12:00 | GLOBE | Gyre Therapeutics Expands Board of Directors with.. |
| 15/12/2023 | 15:04 | PRNUS | Totus Medicines Announces Appointment of Nassim Usman,.. |
| 13/11/2023 | 13:00 | GLOBE | Gyre Therapeutics Presents Poster at the American.. |
| 02/11/2023 | 22:00 | EDGAR2 | Form 8-K - Current report |
| 01/11/2023 | 22:18 | EDGAR2 | Form 424B3 - Prospectus [Rule 424(b)(3)] |
| 01/11/2023 | 21:58 | EDGAR2 | Form SC 13D/A - General statement of acquisition of.. |
